Trial Profile
Omalizumab for the Treatment of Chronic Rhinosinusitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2015
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Rhinosinusitis
- Focus Therapeutic Use
- 12 May 2015 New trial record